Ghannam et al., 2024 - Google Patents
Ventricular tachycardia ablation in patients with desmoplakin cardiomyopathyGhannam et al., 2024
- Document ID
- 14671000504498252073
- Author
- Ghannam M
- Liang J
- Hoogendoorn J
- Zeppenfeld K
- Siontis K
- Asirvatham S
- Sacher F
- Maury P
- Gandjbakhch E
- Morady F
- Bogun F
- Publication year
- Publication venue
- Clinical Electrophysiology
External Links
Snippet
Background Desmoplakin (DSP) pathogenic variants are rare causes of arrhythmogenic cardiomyopathy and often involve the right and left ventricles. Ventricular tachycardia (VT) ablations may be required in these patients, but procedural characteristics have not been …
- 206010047302 ventricular tachycardia 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
- A61B5/046—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3925—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
- A61B6/504—Clinical applications involving diagnosis of blood vessels, e.g. by angiography
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation | |
El-Am et al. | Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis | |
Komatsu et al. | Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia | |
Ouyang et al. | Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation | |
Kistler et al. | Electrophysiologic and electroanatomic changes in the human atrium associated with age | |
Nakahara et al. | Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy: implications for catheter ablation of hemodynamically unstable ventricular tachycardia | |
Sparks et al. | Left atrial “stunning” following radiofrequency catheter ablation of chronic atrial flutter | |
Soejima et al. | Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars | |
Lakkireddy et al. | Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders | |
Triedman et al. | Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease | |
Neuberger et al. | Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat | |
Okuyama et al. | High resolution mapping of the pulmonary vein and the vein of Marshall during induced atrial fibrillation and atrial tachycardia in a canine model of pacing-induced congestive heart failure | |
Fernandez-Armenta et al. | Safety and outcomes of ventricular tachycardia substrate ablation during sinus rhythm: a prospective multicenter registry | |
Hayashi et al. | Trends in successful ablation sites and outcomes of ablation for idiopathic outflow tract ventricular arrhythmias | |
Anderson et al. | Focal ventricular tachycardias in structural heart disease: prevalence, characteristics, and clinical outcomes after catheter ablation | |
Bunch et al. | Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia | |
Kapel et al. | Slow conducting electroanatomic isthmuses: an important link between QRS duration and ventricular tachycardia in tetralogy of Fallot | |
Ghannam et al. | Mapping and ablation of intramural ventricular arrhythmias: a stepwise approach focused on the site of origin | |
Dabbagh et al. | Magnetic resonance mapping of catheter ablation lesions after post-infarction ventricular tachycardia ablation | |
Ezzeddine et al. | Substrate characterization and outcomes of catheter ablation of ventricular arrhythmias in patients with mitral annular disjunction | |
Tedrow et al. | Worldwide experience with an irrigated needle catheter for ablation of refractory ventricular arrhythmias | |
Ghannam et al. | Ventricular tachycardia ablation in patients with desmoplakin cardiomyopathy | |
De Potter et al. | First-in-human experience with ultra-low temperature cryoablation for monomorphic ventricular tachycardia | |
Steinfurt et al. | Initial clinical experience with a novel 8-spline high-resolution mapping catheter | |
Nakamura et al. | Atrioventricular block during catheter ablation for ventricular arrhythmias |